247 filings
Page 3 of 13
8-K
an1h5p
14 Apr 21
Lumos Pharma to Host Key Opinion Leader Event on LUM-201 for the Treatment of Pediatric Growth Hormone Deficiency
4:16pm
8-K
w2qqfh bggcc31tm
23 Mar 21
Data show greater GH response in pediatric growth hormone deficiency (PGHD) from LUM-201 than standard GH secretagogues
4:19pm
8-K
h2mkst m5
9 Mar 21
Lumos Pharma Reports Full Year 2020 Financial Results and Provides Update on OraGrowtH Trials in PGHD
4:26pm
8-K
trunyod5q2r52v bkt
4 Mar 21
Other Events
9:09am
8-K
xl5u3 mhbwwp6vse5
2 Mar 21
Other Events
4:30pm
8-K
reep9ckx rq6fr
16 Feb 21
Lumos Pharma Announces Changes to its Board of Directors
12:00am
8-K
r5zahh3d nk3
8 Feb 21
Departure of Directors or Certain Officers
5:05pm
8-K
s5ye dnjjjl6l9
30 Dec 20
Entry into a Material Definitive Agreement
4:44pm
8-K
6kgo3atybj6uqtb09dnp
21 Dec 20
Other Events
4:34pm
8-K
ranp1tx squ1
11 Dec 20
Other Events
4:11pm
8-K
0n07y3ic6wyf2psi0
10 Nov 20
Lumos Pharma Announces the Initiation of Phase 2b OraGrowtH210 Trial and Reports Third Quarter 2020 Financial Results
4:31pm
8-K
jtzltrt
13 Aug 20
Lumos Pharma Reports Second Quarter 2020 Results and Provides Update on Clinical and Corporate Activities
4:36pm
8-K
tht a7a0j9
3 Aug 20
Submission of Matters to a Vote of Security Holders
4:58pm
8-K
eh5wgjl3h25zl6qo8dom
27 Jul 20
Lumos Pharma Announces Sale of Priority Review Voucher
4:31pm
8-K
rpyuh
9 Jun 20
Other Events
5:07pm
8-K/A
xf6yypmg 5kep4
1 Jun 20
Other Events
12:00am
8-K
7ceudxrp
28 May 20
Lumos Pharma Reports First Quarter 2020 Results and Provides Update on Clinical and Corporate Activities
4:41pm
8-K
oy70wivx
14 May 20
Other Events
4:16pm
8-K
j4sclo my03
24 Apr 20
Other Events
10:04am
8-K
6ebxqmqi
2 Apr 20
Departure of Directors or Certain Officers
4:32pm